Living-Donor Kidney Transplant From Hepatitis B Surface Antigen-Positive Donors to Hepatitis B Antibody-Positive Recipients Without Hepatitis B Immunoglobulin Prophylaxis in an Endemic Country
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jun, Heungman | - |
dc.contributor.author | Kim, Myung Gyu | - |
dc.contributor.author | Park, Kwan Tae | - |
dc.contributor.author | Jung, Cheol Woong | - |
dc.date.accessioned | 2021-09-04T17:35:19Z | - |
dc.date.available | 2021-09-04T17:35:19Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2015-04 | - |
dc.identifier.issn | 1304-0855 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/93918 | - |
dc.description.abstract | Objectives: Living-donor kidney transplant from donors who are chronically infected with hepatitis B virus can be considered as a possibility to compensate for insufficiency of organ transplants, particularly in a hepatitis B virus endemic country. In this study, the safety and efficacy were reviewed retrospectively in living-donor kidney transplant from donors who were chronically infected with hepatitis B virus. Materials and Methods: In the years between 2012 and 2013, we transplanted 4 renal grafts from hepatitis B surface antigen-positive living donors to antihepatitis B antibody-positive recipients. Lamivudine was prescribed for recipients after transplant without hepatitis B immunoglobulin. Results: In 1-year follow-up, there were no abnormal findings in the levels of renal and liver enzymes, and there was no unwanted sero-conversion to positive hepatitis B surface antigen. Conclusions: When combined with careful hepatitis B virus-monitoring, renal grafts from hepatitis B surface antigen-positive living donors can be transplanted to hepatitis B antibody-positive recipients, without the need for hepatitis B immunoglobulin prophylaxis, in a hepatitis B virus endemic country. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | BASKENT UNIV | - |
dc.subject | RENAL-TRANSPLANTATION | - |
dc.subject | MANAGEMENT | - |
dc.title | Living-Donor Kidney Transplant From Hepatitis B Surface Antigen-Positive Donors to Hepatitis B Antibody-Positive Recipients Without Hepatitis B Immunoglobulin Prophylaxis in an Endemic Country | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Cheol Woong | - |
dc.identifier.doi | 10.6002/ect.mesot2014.P60 | - |
dc.identifier.scopusid | 2-s2.0-84939813634 | - |
dc.identifier.wosid | 000355058400050 | - |
dc.identifier.bibliographicCitation | EXPERIMENTAL AND CLINICAL TRANSPLANTATION, v.13, pp.256 - 258 | - |
dc.relation.isPartOf | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | - |
dc.citation.title | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | - |
dc.citation.volume | 13 | - |
dc.citation.startPage | 256 | - |
dc.citation.endPage | 258 | - |
dc.type.rims | ART | - |
dc.type.docType | Article; Proceedings Paper | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | RENAL-TRANSPLANTATION | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordAuthor | End-stage renal disease | - |
dc.subject.keywordAuthor | Infectious diseases | - |
dc.subject.keywordAuthor | Lamivudine | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.